Integrated care

CCGs poised to defy pharma by switching to cheaper, unlicensed drug

By 2014-11-27T12:12:00

Injection

Clinical commissioning groups across England are mulling the use of an unlicensed drug which could save the NHS millions of pounds, HSJ has learned

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here